Xymelin Eco, spray 140 mcg/dose 10 ml

A vasoconstrictor for local use in ENT practice. Xylometazoline has alpha-adrenomimetic action. Causes narrowing of the blood vessels of the nasal mucosa, thus eliminating edema and hyperemia of the nasopharyngeal mucosa.

Easily eases nasal breathing in rhinitis.

In therapeutic concentrations it does not irritate the mucosa and does not cause hyperemia. The action occurs within a few minutes after application and lasts for 10-12 hours.

Indications

Acute respiratory diseases with symptoms of rhinitis (runny nose), acute allergic rhinitis, hay fever, sinusitis, eustachitis, otitis media (to reduce swelling of the nasopharyngeal mucosa).

Preparing the patient for diagnostic manipulations in the nasal passages.

Pharmacological effect

Vasoconstrictor drug for local use in ENT practice. Xylometazoline has an alpha-adrenomimetic effect. Causes a narrowing of the blood vessels of the nasal mucosa, thus eliminating swelling and hyperemia of the nasopharyngeal mucosa.

Facilitates nasal breathing during rhinitis.

In therapeutic concentrations it does not irritate the mucous membranes and does not cause hyperemia. The effect occurs a few minutes after application and lasts for 10-12 hours.

Special instructions

Should not be used for a long time, for example for chronic rhinitis.

Active ingredient

Xylometazoline

Composition

1 ml spray contains:

Active ingredient:

xylometazoline hydrochloride 1 mg;

Excipients:

sodium hydrogen phosphate dihydrate,

sodium dihydrogen phosphate dihydrate,

disodium edetate,

sodium chloride,

purified water.

Pregnancy

During pregnancy and lactation, the drug should be used only after a thorough assessment of the risk-benefit ratio for the mother and fetus; recommended doses should not be exceeded.

The aerosol is not prescribed to children under 3 years of age. Nasal drops 0.1% for children under 2 years of age are prescribed only by a doctor.

Contraindications

Individual hypersensitivity to the components of the drug, hypertension, tachycardia, severe atherosclerosis, glaucoma, atrophic rhinitis, thyrotoxicosis, history of surgical interventions on the meninges, age under 18 years.

Side Effects

Local reactions: with frequent and/or prolonged use – irritation and/or dryness of the nasopharyngeal mucosa, burning, tingling, sneezing, hypersecretion; rarely – swelling of the nasal mucosa.

Systemic reactions: rarely – palpitations, tachycardia, arrhythmias, increased blood pressure, headache, vomiting, insomnia, blurred vision; with long-term use in high doses – depression.

Interaction

Incompatible with MAO inhibitors and tricyclic antidepressants.

Overdose

Symptoms: increased side effects.

Treatment: symptomatic therapy.

Storage conditions

At a temperature not exceeding 30 °C

Shelf life

3 years

Manufacturer

Takeda GmbH, Germany